XNAS · KARD
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Kardigan, Inc. Common Stock

Kardigan, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$21.02
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
KARD
Kardigan, Inc. Common Stock
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

63/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is KARD moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading KARD catalysts
About Kardigan, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2026
Country
US

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$21.02
Last session
Day high
$21.02
Last session
Day low
$21.02
Last session
Previous close
$21.02
52W high
$25.90
-18.84% from high
52W low
$19.73
21% of range
Market cap
$2B
EPS
$-17.3200
Beta
2.10
Shares out
93.5M
Avg volume
235.6K
VWAP
$21.02
Last session
Price history computed in-house
1W
+2.29%
1M
+1.35%
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 21%

KARD overview

Veridion Score
63
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around KARD.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading KARD Form 4 filings
Public disclosures

Congress activity in KARD

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for KARD in the cached public ledger.

Federal contracts

KARD contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KARD in this window.
Lobbying spend

KARD lobbying filings, year to date.

Registered lobbying filings matched to Kardigan, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KARD in this window.
Loading news for KARD
Analyst ratings
Sovereign unlock shows live analyst consensus for KARD.
Options
Sovereign unlock shows live options positioning for KARD.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.